Cargando…
Migraine Characteristics, Comorbidities, Healthcare Resource Utilization, and Associated Costs of Early Users of Erenumab in the USA: A Retrospective Cohort Study Using Administrative Claims Data
INTRODUCTION: Erenumab is indicated for migraine preventive treatment in adults. The objective of this study was to provide descriptive information on real-world use of erenumab including patient profile and treatment patterns. METHODS: We completed a retrospective review of US data (through May 201...
Autores principales: | Chandler, David, Szekely, Christine, Aggarwal, Shivani, Cyprien, Lori, Bensink, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586283/ https://www.ncbi.nlm.nih.gov/pubmed/34533779 http://dx.doi.org/10.1007/s40122-021-00319-z |
Ejemplares similares
-
Correction to: Migraine Characteristics, Comorbidities, Healthcare Resource Utilization, and Associated Costs of Early Users of Erenumab in the USA: A Retrospective Cohort Study Using Administrative Claims Data
por: Chandler, David, et al.
Publicado: (2023) -
Erenumab in the Treatment of Comorbid Trigeminal Neuralgia in Patients With Migraine
por: Katsuki, Masahito, et al.
Publicado: (2023) -
Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database study
por: Tepper, Stewart J., et al.
Publicado: (2021) -
Real-World Treatment Profiles, Clinical Outcomes, and Healthcare Resource Utilization of Patients with Migraine Prescribed Erenumab: A Multicenter Chart-Review Study of US Headache Centers
por: Faust, Elizabeth, et al.
Publicado: (2021) -
The role of erenumab in the treatment of migraine
por: Andreou, Anna P., et al.
Publicado: (2020)